News
DMD Advocates Advises Molbio Diagnostics on a $30 Million Investment in OptraSCAN
09 Jan 2025
- DMD Advocates
- Deal Reporting
DMD Advocates advised Molbio Diagnostics on its $30 million investment for acquiring a majority stake in OptraSCAN Inc., a US-based company specializing in digital pathology solutions.
This acquisition enables Molbio to integrate OptraSCAN’s technology into its portfolio, strengthening its position in the diagnostics market both in India and internationally. For OptraSCAN, the deal provides capital for growth and expansion while aligning its operations with Molbio’s strategic direction. This partnership enhances the capabilities of both companies, drives innovation, and increases their competitive edge in the healthcare and diagnostics sectors.
The transaction was led by Ayesha Rai (Partner) along with Pooja Shah (Principal Associate) and Vanshikha Choraria (Associate). The legal due diligence team consisted of Kajal Tandon (Counsel), Luv Madan (Associate), Parizad Irani (Associate), and Tarush Bhandari (Associate).
Rashi Dhir (Senior Partner & Head of Corporate) and Vihang Virkar (Lead Partner) provided crucial inputs on the transaction.
DMD Advocates worked with Ryan Roberts (Partner) from Roberts Zimmerman PLLC, a Texas-based law firm, for US law-related matters.
